Načítá se...
The Cost Effectiveness of Screening Newborns for Congenital Adrenal Hyperplasia
OBJECTIVE: To assess the cost effectiveness of newborn screening for congenital adrenal hyperplasia (CAH) in the U.S. newborn population. METHODS: We constructed a decision model to estimate the incremental cost-effectiveness ratio (ICER) of CAH screening compared to a strategy of no screening. Two...
Uloženo v:
| Vydáno v: | Public Health Genomics |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2008
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6706242/ https://ncbi.nlm.nih.gov/pubmed/19039250 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000156115 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|